scispace - formally typeset
T

Timothy E. Van Meter

Researcher at Virginia Commonwealth University

Publications -  42
Citations -  6608

Timothy E. Van Meter is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Medulloblastoma & Glioma. The author has an hindex of 25, co-authored 38 publications receiving 5558 citations. Previous affiliations of Timothy E. Van Meter include VCU Medical Center.

Papers
More filters
Journal ArticleDOI

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Dominik Sturm, +82 more
- 16 Oct 2012 - 
TL;DR: It is demonstrated that each H3F3A mutation defines an epigenetic subgroup of GBM with a distinct global methylation pattern, and that they are mutually exclusive with IDH1 mutations, which characterize a third mutation-defined subgroup.
Journal ArticleDOI

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Paul A. Northcott, +139 more
- 02 Aug 2012 - 
TL;DR: Somatic copy number aberrations (SCNAs) in 1,087 unique medulloblastomas are reported, including recurrent events targeting TGF-β signalling in Group 3, and NF-κB signalling in Groups 4, which suggest future avenues for rational, targeted therapy.
Journal ArticleDOI

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Florence M.G. Cavalli, +101 more
- 12 Jun 2017 - 
TL;DR: Similarity network fusion (SNF) applied to genome-wide DNA methylation and gene expression data across 763 primary samples identifies very homogeneous clusters of patients, supporting the presence of medulloblastoma subtypes.
Journal ArticleDOI

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Dominik Sturm, +122 more
- 25 Feb 2016 - 
TL;DR: It is demonstrated that a significant proportion of institutionally diagnosed CNS-PNETs display molecular profiles indistinguishable from those of various other well-defined CNS tumor entities, facilitating diagnosis and appropriate therapy for patients with these tumors.